Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
Christian Ascoli(University of Illinois Chicago), Patricia W. Finn(Harvard University Press), Cody Schott(University of Illinois Chicago), Benjamin A. Turturice(National Institutes of Health), David L. Perkins(United States Fish and Wildlife Service), Naomi Ecanow(University of Illinois Chicago), Yue Huang(Huazhong Agricultural University), Nadera Sweiss(University of Illinois Chicago), Wangfei Wang(University of Illinois Chicago)
Cited by 17
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.
|Journal of Clinical Investigation|1997|336
Racial Difference in Sarcoidosis Mortality in the United States
|CHEST Journal|2014|251
Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction
|Circulation Cardiovascular Imaging|2016|217